12:00 AM
Apr 27, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Micromet preclinical data

In vitro data showed that a bispecific T cell engager (BiTE) antibody derived from panitumumab and genetically fused to a primate cross-reactive, human single-chain antibody against CD3...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >